Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective? / Hughes, D.; Hughes, D.A.; Pirmohamed, M.
Yn: Value in Health, Cyfrol 6, Rhif 6, 01.11.2003, t. 749.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Hughes, D, Hughes, DA & Pirmohamed, M 2003, 'Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?', Value in Health, cyfrol. 6, rhif 6, tt. 749.

APA

Hughes, D., Hughes, D. A., & Pirmohamed, M. (2003). Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective? Value in Health, 6(6), 749.

CBE

Hughes D, Hughes DA, Pirmohamed M. 2003. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Value in Health. 6(6):749.

MLA

Hughes, D., D.A. Hughes a M. Pirmohamed. "Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?". Value in Health. 2003, 6(6). 749.

VancouverVancouver

Hughes D, Hughes DA, Pirmohamed M. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective? Value in Health. 2003 Tach 1;6(6):749.

Author

Hughes, D. ; Hughes, D.A. ; Pirmohamed, M. / Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Yn: Value in Health. 2003 ; Cyfrol 6, Rhif 6. tt. 749.

RIS

TY - JOUR

T1 - Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

AU - Hughes, D.

AU - Hughes, D.A.

AU - Pirmohamed, M.

PY - 2003/11/1

Y1 - 2003/11/1

M3 - Article

VL - 6

SP - 749

JO - Value in Health

JF - Value in Health

SN - 1524-4733

IS - 6

ER -